We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Diagnostic Tools Unveiled at EuroMedLab Exhibition

By LabMedica International staff writers
Posted on 27 Jun 2017
A major international manufacturer of automated diagnostic instruments and point-of-care diagnostic products has changed its name, a change that was highlighted at the IFCC EuroMedLab Athens June 12-14, 2017, exhibition.

Siemens Healthineers (Erlangen, Germany), which is the separately managed healthcare business of Siemens AG (Munich, Germany) presented its latest Atellica Portfolio offerings at the Athens exhibition.

The Portfolio included: Atellica Solution (flexible, scalable, automation-ready immunoassay, and clinical chemistry analyzers), Atellica 1500 Automated Urinalysis System (fully digital, automated urinalysis system), Atellica NEPH 630 System (mid-volume, dedicated nephelometric system that simplifies specialty protein testing), Atellica COAG 360 System (fully automated high-volume coagulation system that unifies five testing methodologies), Atellica MDX 160 System (flexible, automated molecular system with maximum productivity for multiple sample types), and Atellica PM 1.0 Software (process management software to optimize lab operations through data analytics and visualization).

In addition, the Athens presentation featured the RAPIDComm Data Management System, which enables centrally managed point-of-care testing programs through a single customizable interface.

“The 2017 product display from Siemens Healthineers represents our focus on engineering success and pioneering healthcare,” said Franz Walt, president of laboratory diagnostics at Siemens Healthineers. More...
“The Atellica portfolio epitomizes engineering excellence - with revolutionary innovations designed to give lab professionals control and simplicity so they can spend less time on operations and more time on driving better outcomes.”

“The informatics solutions from Siemens Healthineers are designed to address connectivity challenges to help position point-of-care testing programs for success,” said Peter Koerte, president of point-of-care diagnostics at Siemens Healthineers. “Through open connectivity to more than 150 devices from all leading point-of-care vendors, we deliver secure - yet flexible - connectivity options that increase both choice and performance for greater efficiency.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Drug Testing Assays
Atellica DT 250 Analyzer
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Industry

view channel
Image: NeoGenomics selected Indica Labs’ HALO AP platform to eable its digital pathology operations through a scalable, cloud-based framework (Photo courtesy of Indica Labs)

Expanded Partnership Scales AI-Powered Digital Pathology for Oncology

Oncology diagnostics rely on pathology and biomarker information to guide personalized treatment. As computational pathology and artificial intelligence (AI) expand insights from tissue analysis, laboratories... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.